2017 Annual Meeting

College of American Pathologists

March 5 2017, 8:30am to 12:00pm

Description

College of American Pathologists

Mission Control-The Value of Cancer Protocols, Staging Manuals, and the Key Revisions to Select Tumor Sites

Sunday, March 5, 2017
8:30 AM 12:00 PM
CC Hemisfair 1

 

Session Credits: 3 CME

 

Moderators: Joseph D. Khoury, MD, University of Texas MD Anderson Cancer Center, Houston, TX
Larissa V. Furtado, MD, FCAP, University of Utah/ARUP Laboratories, Salt Lake City, UT

Course Description:
Since 1986, the CAP Cancer Protocols have served as a resource and reference for complete reporting of malignant tumors, including American Joint Committee on Cancer (AJCC) staging and the World Health Organization (WHO) histologic type standard elements. The CAP Cancer Committee is responsible for producing and maintaining these important reference resources and cancer reporting tools. The protocols have grown in number and scope over the past several years, and have influenced important global efforts such as the International Collaboration on Cancer Reporting (ICCR) datasets.

Reporting cancer elements has progressed from the traditional narrative reporting style with observed characteristics of the neoplastic cells to more highly arranged synoptic reports that better optimize readability with computer reporting systems. The current drive to develop structured reporting for cancer attempts to organize the data elements in the synoptic field to integrate with the laboratory information system (LIS) and then with the electronic medical record (EMR). The CAP Cancer Protocols are intended to: 1) support pathologists in generating “complete” reports that contain all the core data elements, and 2) ensure that the core data elements are clear and unambiguous for clinicians. The CAP Cancer Protocols are evolving to meet the needs for greater data usage and integration as the cancer community develops new therapies and big-data research.

Upon completion of this educational activity, participants should be able to:

  • Explain the value of the cancer protocols to patient care
  • Distinguish the difference between synoptic reporting and structured reporting and the value both bring to cancer patients
  • Demonstrate the key changes to the staging elements with the AJCC 8th edition Cancer Staging Manual (TNM)

Agenda

8:30 AM

Introduction
Joseph D. Khoury, MD, University of Texas MD Anderson Cancer Center, Houston, TX
Larissa V. Furtado, MD, FCAP, University of Utah/ ARUP Laboratories, Salt Lake City, UT

8:35 AM

Why Cancer Protocols?
Thomas P. Baker, MD, The Joint Pathology Center, Silver Spring, MD

9:00 AM

Common Changes in TNM Staging
Thomas Baker, MD, The Joint Pathology Center, Silver Spring, MD

9:25 AM

Pathologic Staging Updates in Breast Cancer
Patrick L. Fitzgibbons, MD, St. Jude Medical Center, Fullerton, CA

9:55 AM

Break

10:25 AM

Pathologic Staging Updates in Urologic Cancers, Including Prostate, Bladder, Kidney and Testis
Ming Zhou, MD, PhD, University of Texas Southwestern Medical Center, Dallas, TX

10:55 AM

Pathologic Staging Updates in Colorectal Cancer
Sanjay Kakar, MD, University of California San Francisco, San Francisco, CA

11:25 AM

Pathologic Staging Updates in Lung Cancer
Sanja Dacic, MD, PhD, University of Pittsburgh Health System, Pittsburgh, PA

11:55 AM

Concluding Remarks

Meetings

home-circle-inset-1
view more